Oncology breast testing
ID: HT001425SS0001Type: Sources Sought
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)DEFENSE HEALTH AGENCYFALLS CHURCH, VA, 22042, USA

NAICS

Medical Laboratories (621511)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Original Source

https://sam.gov/opp/bbb24f12c8b44d629fa7c04a9fd56602/view
Timeline
    Description

    The Department of Defense, through the Defense Health Agency (DHA), is seeking sources for oncology breast testing services. This procurement aims to identify qualified medical laboratories capable of providing specialized testing services critical for cancer diagnosis and treatment. The services will be performed in Bethesda, Maryland, and are essential for supporting the health and readiness of military personnel and their families. Interested parties can reach out to Edgar DuChemin at edgar.r.duchemin.civ@health.mil or call 703-275-6348 for further information regarding this opportunity.

    Point(s) of Contact
    Edgar DuChemin
    (703) 275-6348
    edgar.r.duchemin.civ@health.mil
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Oncology breast testing
    Currently viewing
    Sources Sought
    Similar Opportunities
    Reference Laboratory Testing Services for the Landstuhl Regional Medical Center (LRMC), Germany
    Buyer not available
    The Department of Defense, through the Department of the Army, is seeking qualified contractors to provide Reference Laboratory Testing Services for the Landstuhl Regional Medical Center (LRMC) in Germany. The procurement aims to ensure compliance with College of American Pathologists (CAP) standards while delivering a wide range of laboratory tests, including timely reporting of results within 72 hours of specimen receipt. This contract is crucial for maintaining high-quality healthcare services for U.S. military personnel and their families stationed in Europe. Interested parties should contact Henning Mayer-Goldstein at henningfalk.mayer-goldstein.ln@health.mil or Matthew R. Elden at matthew.r.elden.civ@health.mil for further details, with the contract period set from May 2025 to April 2026.
    NOTICE OF INTENT TO SOLE SOURCE
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), has issued a Special Notice regarding its intent to sole source a procurement opportunity for medical, dental, and hospital equipment and supplies. This opportunity is set aside for small businesses under the Total Small Business Set-Aside (FAR 19.5) and falls under the NAICS code 423450, which pertains to medical and surgical instruments, equipment, and supplies. The goods and services sought are critical for supporting healthcare operations, particularly in military settings, and will be performed in Bethesda, Maryland. Interested parties can reach out to Edgar DuChemin at edgar.r.duchemin.civ@health.mil or call 703-275-6348 for further details.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Buyer not available
    The Department of Defense (DoD) is soliciting quotations for pharmaceutical agents as part of its Pharmacy Uniform Formulary Blanket Purchase Agreement and Additional Discount Program, managed by the Defense Health Agency (DHA). This procurement aims to establish an effective pharmacy benefits program for the Military Health System (MHS), focusing on the selection and classification of pharmaceutical agents based on clinical and cost-effectiveness for military beneficiaries. The upcoming Pharmacy and Therapeutics (P&T) Committee meeting, scheduled for May 7-8, 2025, will review specific drug classes, including Breast Cancer Agents and Targeted Immunomodulatory Biologics, with quotes due by March 20, 2025. Interested vendors should direct inquiries to Tracy Banks at tracy.e.banks2.civ@health.mil or Julianne Canaley at julianne.m.canaley.ctr@health.mil for further details.
    Q301--Reference Lab Services for Detroit VAMC
    Buyer not available
    The Department of Veterans Affairs is seeking qualified vendors to provide Reference Laboratory Services for the Detroit VA Medical Center. This procurement aims to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract, focusing on laboratory testing, specimen transport, and reporting services essential for veteran healthcare. The initiative underscores the importance of high-quality laboratory services in supporting timely diagnostics and treatment, with specific requirements including adherence to VHA standards and various accreditations such as CLIA and CAP. Interested Service-Disabled Veteran-Owned Small Businesses (SDVOSB) must submit their capability information to Contract Specialist Morgan Stein at Morgan.Stein@va.gov by the specified deadline to participate in this opportunity.
    Biomedical Research Application Evaluation and Support Services (BRAES)
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for Biomedical Research Application Evaluation and Support Services (BRAES) to enhance the management of biomedical research applications under the Congressionally Directed Medical Research Programs (CDMRP). The procurement aims to provide comprehensive evaluation services, including compliance reviews, peer review management, and technical support, utilizing advanced systems for application submission and data management. This initiative is crucial for ensuring effective oversight and innovation in biomedical research, particularly for military personnel and the general public. Interested parties can contact Deanna Moose at deanna.s.moose.civ@health.mil or Jeanette Wolfe at jeanette.m.wolfe.civ@health.mil for further details, with proposals due as specified in the attached documents.
    Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to disease diagnosis and patient health assessment. The procurement aims to establish contracts for services that comply with federal, state, and local regulations, including necessary licensing and accreditation, while ensuring that only new items are provided and that grey market goods are strictly prohibited. This opportunity is critical for enhancing the quality of healthcare services provided to veterans, with a focus on compliance with the Trade Agreements Act and other regulatory requirements. Interested vendors should contact Contract Specialist Brian O'Connell at Brian.O'connell@va.gov for further details, and they must adhere to the submission deadlines outlined in the solicitation documents.
    OCONUS Hematology Support
    Buyer not available
    The Department of Defense, specifically the Department of the Army, is seeking proposals for OCONUS Hematology Support under a Combined Synopsis/Solicitation notice. The procurement involves providing automated hematology analyzers, reagents, maintenance, and training across multiple U.S. Army Medical facilities in Europe, operating on a Cost Per Reportable Result (CPRR) basis. This initiative is crucial for enhancing clinical capabilities and ensuring high-quality healthcare services for military personnel, with a contract period from May 1, 2025, to September 30, 2029. Interested vendors should note that the contract will be awarded on March 1, 2025, and are encouraged to contact Henning Mayer-Goldstein at henningfalk.mayer-goldstein.ln@health.mil or Matthew R. Elden at matthew.r.elden.civ@health.mil for further details.
    Microbiological Identification/Susceptibility (ID/AST) testing support for the Landstuhl Regional Medical Center (LRMC), Germany
    Buyer not available
    The Department of Defense, through the Department of the Army, is seeking contractors to provide microbiological identification and susceptibility testing support for the Landstuhl Regional Medical Center (LRMC) in Germany. The procurement involves a five-year contract for the delivery, installation, maintenance, and repair of an Organism Sensitivity and Identification System, along with necessary reagents and supplies, adhering to Clinical Laboratory Improvement Amendments guidelines. This testing support is crucial for ensuring accurate diagnostics and effective treatment protocols within military medical facilities. Interested contractors should contact Henning Mayer-Goldstein at henningfalk.mayer-goldstein.ln@health.mil or Matthew R. Elden at matthew.r.elden.civ@health.mil for further details, and must comply with the submission requirements outlined in the solicitation documents, with deadlines specified in the amendment.
    Notice of Intent to Sole Source to Extend Services for N6264520P0020 - Molecular Assay-Analyzers
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), intends to issue a sole source bridge contract to BioFire Defense, LLC for the provision of a molecular diagnostic laboratory analyzer, along with necessary assays, reagents, and consumables at Naval Hospital Camp Pendleton and Naval Medical Center Portsmouth. The contract, which is set to run from April 16, 2025, to October 15, 2025, with an option for an additional six months, requires the analyzer to perform a variety of tests using polymerase chain reaction (PCR) technology, including respiratory, blood culture, gastrointestinal, and meningitis/encephalitis assays, while ensuring compliance with FDA regulations. This procurement is critical for maintaining effective diagnostic capabilities within military medical facilities, and interested vendors must submit capability statements by February 28, 2025, as the procurement will not be open for competitive proposals. For further inquiries, vendors can contact Margaret Suever at margaret.a.suever.civ@health.mil or by phone at 210-952-8283.
    Histology
    Buyer not available
    The Department of Defense, specifically the Department of the Army, is seeking potential contractors to provide reagents, equipment, and services for high throughput specimen processing in an Anatomic Pathology Lab at the Brooke Army Medical Center (BAMC) in Fort Sam Houston, Texas. The procurement aims to enhance capabilities in various staining techniques and image management, with a focus on integrating Laboratory Information Systems (LIS) to improve workflow efficiency from specimen receipt to archiving. This Sources Sought notice serves as a market research tool to evaluate the capacity of both small and large businesses, particularly those under socioeconomic categories such as Service-Disabled Veteran-Owned and Women-Owned Small Businesses, to meet BAMC’s requirements. Interested parties must submit detailed capability statements by February 5, 2025, and any inquiries should be directed to Colleen Rye at colleen.m.rye.civ@health.mil or Salameya Paulouskaya at salameya.paulouskaya2.civ@health.mil.